Glaukos Stock Price - GKOS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 64.26 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Glaukos Corporation GKOS NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  1.45 2.31% 64.26 64.88 62.94 62.94 62.81 16:01:02
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,046 363,504 $ 63.93 $ 23,239,556 448,229 50.60 - 84.65
Last Trade Time Type Quantity Stock Price Currency
17:37:00 formt 157 $ 64.26 USD

Glaukos Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.37B 36.86M $ -12.95M -0.37 -361.96 36.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.47M $ - 0.00% - -

more financials information »

Glaukos News

Loading Messages....

Latest GKOS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GKOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week65.6466.1156.1761.15814,652-1.38-2.1%
1 Month61.9366.7056.1762.87470,5832.333.76%
3 Months63.5976.0656.1764.22483,8520.671.05%
6 Months65.0084.6556.1767.59454,295-0.74-1.14%
1 Year60.89584.6550.6067.16433,5053.375.53%
3 Years34.2684.6523.07547.61513,03130.0087.57%
5 Years29.1184.6514.2543.42447,85435.15120.75%

Glaukos Description

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.